Role of Ubiquitination in the Occurrence and Development of Osteoporosis (Review)

Overview

Journal Int J Mol Med

Specialty Genetics

Date 2024 Jun 28

PMID 38940355

Authors

Xiaoxia Fan

Rong Zhang

Guocai Xu

Peiyun Fan

Wei Luo

Chunmei Cai

Ri-Li Ge

Affiliations

Soon will be listed here.

Abstract

The ubiquitin (Ub)‑proteasome system (UPS) plays a pivotal role in maintaining protein homeostasis and function to modulate various cellular processes including skeletal cell differentiation and bone homeostasis. The Ub ligase E3 promotes the transfer of Ub to the target protein, especially transcription factors, to regulate the proliferation, differentiation and survival of bone cells, as well as bone formation. In turn, the deubiquitinating enzyme removes Ub from modified substrate proteins to orchestrate bone remodeling. As a result of abnormal regulation of ubiquitination, bone cell differentiation exhibits disorder and then bone homeostasis is affected, consequently leading to osteoporosis. The present review discussed the role and mechanism of UPS in bone remodeling. However, the specific mechanism of UPS in the process of bone remodeling is still not fully understood and further research is required. The study of the mechanism of action of UPS can provide new ideas and methods for the prevention and treatment of osteoporosis. In addition, the most commonly used osteoporosis drugs that target ubiquitination processes in the clinic are discussed in the current review.

Citing Articles

Effects of ADRM1 on osteoblast differentiation and mineralization in osteoporosis.

Zhuang H, Lin Y, Lin C, Zheng M, Yao X, Xu Y Am J Transl Res. 2025; 17(1):416-428.

PMID: 39959199 PMC: 11826214. DOI: 10.62347/XSOV4523.

Hypoxia Promotes Osteoclast Differentiation by Weakening USP18-Mediated Suppression on the NF-κB Signaling Pathway.

Fan X, Li B, Chai S, Zhang R, Cai C, Ge R Int J Mol Sci. 2025; 26(1.

PMID: 39795869 PMC: 11719700. DOI: 10.3390/ijms26010010.

Innovative Drug Discovery: Targeting Cancer, Neurological Disorders, and Obesity.

Kargbo R ACS Med Chem Lett. 2024; 15(9):1440-1442.

PMID: 39291014 PMC: 11403755. DOI: 10.1021/acsmedchemlett.4c00411.

References

Kabekkodu S, Shukla V, Varghese V, D Souza J, Chakrabarty S, Satyamoorthy K . Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018; 93(4):1955-1986. DOI: 10.1111/brv.12428. View

Lin Y, Zheng G, Liu H, Wang P, Yuan W, Zhang Y . USP7 promotes the osteoclast differentiation of CD14+ human peripheral blood monocytes in osteoporosis via HMGB1 deubiquitination. J Orthop Translat. 2023; 40:80-91. PMC: 10275958. DOI: 10.1016/j.jot.2023.05.007. View

Eastell R, Rosen C, Black D, Cheung A, Murad M, Shoback D . Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019; 104(5):1595-1622. DOI: 10.1210/jc.2019-00221. View

Xu Z, Greenblatt M, Yan G, Feng H, Sun J, Lotinun S . SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts. Nat Commun. 2017; 8:14570. PMC: 5321737. DOI: 10.1038/ncomms14570. View

Levin V, Jiang X, Kagan R . Estrogen therapy for osteoporosis in the modern era. Osteoporos Int. 2018; 29(5):1049-1055. DOI: 10.1007/s00198-018-4414-z. View

Hu M, Li P, Li M, Li W, Yao T, Wu J . Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 2003; 111(7):1041-54. DOI: 10.1016/s0092-8674(02)01199-6. View

Lian C, Wu Z, Gao B, Peng Y, Liang A, Xu C . Melatonin reversed tumor necrosis factor-alpha-inhibited osteogenesis of human mesenchymal stem cells by stabilizing SMAD1 protein. J Pineal Res. 2016; 61(3):317-27. DOI: 10.1111/jpi.12349. View

Gosset A, Pouilles J, Tremollieres F . Menopausal hormone therapy for the management of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2021; 35(6):101551. DOI: 10.1016/j.beem.2021.101551. View

Deng L, Meng T, Chen L, Wei W, Wang P . The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020; 5(1):11. PMC: 7048745. DOI: 10.1038/s41392-020-0107-0. View

10.

Xie J, Guo J, Kanwal Z, Wu M, Lv X, Ibrahim N . Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations. Int J Endocrinol. 2020; 2020:3236828. PMC: 7501564. DOI: 10.1155/2020/3236828. View

11.

Zhao L, Huang J, Zhang H, Wang Y, Matesic L, Takahata M . Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells. 2011; 29(10):1601-10. PMC: 3708970. DOI: 10.1002/stem.703. View

12.

Prior J, Seifert-Klauss V, Giustini D, Adachi J, Kalyan S, Goshtasebi A . Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization. J Musculoskelet Neuronal Interact. 2017; 17(3):146-154. PMC: 5601259. View

13.

Zhang Y, Cao M, Li Y, Dai G, Lu P, Zhang M . The regulative effect and repercussion of probiotics and prebiotics on osteoporosis: involvement of brain-gut-bone axis. Crit Rev Food Sci Nutr. 2022; 63(25):7510-7528. DOI: 10.1080/10408398.2022.2047005. View

14.

Liu D, Kou X, Chen C, Liu S, Liu Y, Yu W . Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors. Cell Res. 2018; 28(9):918-933. PMC: 6123409. DOI: 10.1038/s41422-018-0070-2. View

15.

Jones D, Wein M, Oukka M, Hofstaetter J, Glimcher M, Glimcher L . Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science. 2006; 312(5777):1223-7. DOI: 10.1126/science.1126313. View

16.

Edwards J, Mundy G . Advances in osteoclast biology: old findings and new insights from mouse models. Nat Rev Rheumatol. 2011; 7(4):235-43. DOI: 10.1038/nrrheum.2011.23. View

17.

Wu M, Chen G, Li Y . TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016; 4:16009. PMC: 4985055. DOI: 10.1038/boneres.2016.9. View

18.

Zhou F, Li F, Fang P, Dai T, Yang B, van Dam H . Ubiquitin-Specific Protease 4 Antagonizes Osteoblast Differentiation Through Dishevelled. J Bone Miner Res. 2016; 31(10):1888-1898. DOI: 10.1002/jbmr.2863. View

19.

Bai Y, Ying Y . The Post-translational Modifications of Smurf2 in TGF-β Signaling. Front Mol Biosci. 2020; 7:128. PMC: 7358609. DOI: 10.3389/fmolb.2020.00128. View

20.

Jin W, Chang M, Paul E, Babu G, Lee A, Reiley W . Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest. 2008; 118(5):1858-66. PMC: 2276399. DOI: 10.1172/JCI34257. View